Healthcare and Life Sciences Value & Outcomes Assessment

Quantify the value of healthcare products

Exponent generates real-world evidence (RWE) and advises clients on approaches to demonstrate the value of drugs, vaccines, diagnostics, and medical devices. This evidence enables informed product stewardship throughout the lifecycle and supports the complex decisions facing payers and health technology assessment organizations.

How do Exponent's multidisciplinary teams help define the value proposition for healthcare products?

Our expert consultants have backgrounds in health services research, epidemiology, outcomes research, and decades of experience generating real-world evidence (RWE) on healthcare product effectiveness, safety, and costs throughout development — and we specialize in post-approval requirements.

We help life sciences companies develop global regulatory roadmaps and optimize market exclusivity for drugs and drug-led combination products. Additionally, we help pharmaceutical companies identify, evaluate, and analyze real-world safety data, including published literature, to develop proactive safety strategies or integrated safety summaries that can be used in regulatory submissions.

Capabilities

Our multidisciplinary teams are ready to provide strategy consulting, RWE analysis, and regulatory support to life sciences companies throughout the product lifecycle to meet the needs of global regulators, payers, providers, and patients.

Real-World Evidence Consulting

Market Access Strategy

Our team helps life sciences companies differentiate their products by evaluating regulatory, human factors, or market adoption strategies intended to facilitate market adoption and accelerate return on investment (ROI). Building on technical assessments and scientific insights, Exponent also helps companies build strategies for reimbursement and to inform pricing negotiations via budget impact or cost-effectiveness models for healthcare payers.

Next-Gen Partnerships

Expanding Health Equity

Digital Health

We partner with life sciences companies to develop and implement digital endpoints from strategy to validation, including regulatory submissions, understanding reimbursement pathways, and choosing the appropriate digital health technology (DHT) for outcome assessment. These services range from identifying the right technology to assessing human factors, clinical viability, maturity, participant usability, and the validity of the resulting data.

Learn more

Regulatory Submission Support

Experts

Our global and comprehensive expertise across industries gives us a deep understanding of current challenges, best industry practices, and the implications of emerging technologies.